Scalp Cooling – An aiding principle
in cancer?
One
of the fatal disease that kills half of the nation’s population is” Cancer”.
Patients who are newly diagnosed by cancer are put in a situation where they
must undergo a lot and the toughest part is the loss of hair. The inevitable
loss of hair is often one of the hardest that most of the women undergo. New
technology has raised in US where the researchers were looking forward to
eliminating this problem from several patient’s lists of worries. The principle
of “Scalp
Cooling” majorly works by reducing the temperature of the
scalp a few degrees immediately before, during and after chemotherapy has been
shown to be highly effective for preserving hair in women receiving neoadjuvant
or adjuvant chemotherapy for early-stage breast cancer.
The
hair
loss
prevention system in this study uses cooling fluid to keep the helmet and scalp
cold, causing cutaneous vasoconstriction, also potentially resulting in reduced
biochemical activity. Experts believe this may help reduce cellular uptake of
the agents and/or decrease susceptibility of hair follicles to
chemotherapy-induced damage. Hair follicles in the growth phase are sensitive
to chemotherapy, resulting in alopecia approximately two weeks after treatment
begins. Effectiveness of scalp cooling for hair preservation varies by
chemotherapy type and dose, and some evidence also suggests by the degree and
duration of cooling. During the trial, women who were treated with scalp
cooling wore a cap or helmet with circulating cooling fluid for half an hour
before chemotherapy, during chemotherapy administration, and for 90 minutes after
the completion of chemotherapy. Patients in the control group did not wear any
cap before, during or after their treatment. The interim results revealed that
48 of 95 patients in the intervention group, or 50.5 percent were able to
preserve their hair, while none of the 47 patients in the control group kept
their hair. Systems are currently being rolled out to hospitals nationwide,
bringing more comfort to more patients that need it the most.
Comments
Post a Comment